AIRS trades 108.3% below Wall Street's consensus target of $4.50.
Last 12 months price action with 12-month analyst target path
The base valuation assumes AIRS achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 5 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of September 24, 2026, AirSculpt Technologies, Inc. (AIRS) has a Wall Street consensus price target of $4.50, based on estimates from 5 covering analysts. With the stock currently trading at $2.16, this represents a potential upside of +108.3%. The company has a market capitalization of $152M.
Analyst price targets range from a low of $4.50 to a high of $4.50, representing a 0% spread in expectations. The median target of $4.50 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 2 analysts rating the stock as a Buy or Strong Buy,3 rating it Hold, and 0 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, AIRS trades at a trailing P/E of -11.4x. Analysts expect EPS to grow +51.7% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 SKINSkinHealth Systems Inc. | $88M | $0.68 | $1.50 | +121.7% | Hold | — | 14 |
 INMDInMode Ltd. | $816M | $14.19 | $19.00 | +33.9% | Hold | 10.9x | 11 |
 SSKNSTRATA Skin Sciences, Inc. | $29441 | $0.01 | — | — | — | — | — |
 ESTAEstablishment Labs Holdings Inc. | $2.0B | $67.76 | $102.00 | +50.5% | Buy | — | 14 |
 MDTMedtronic plc | $114.7B | $89.30 | $98.00 | +9.7% | Buy | 14.9x | 51 |
 SYKStryker Corporation | $104.8B | $273.40 | $372.39 | +36.2% | Buy | 18.2x | 52 |
 ISRGIntuitive Surgical, Inc. | $140.7B | $398.30 | $491.15 | +23.3% | Buy | 36.9x | 57 |
 ABTAbbott Laboratories | $180.3B | $103.53 | $121.50 | +17.4% | Buy | 18.8x | 41 |
 ZBHZimmer Biomet Holdings, Inc. | $17.6B | $90.88 | $103.11 | +13.5% | Hold | 10.7x | 42 |
 LPGDorian LPG Ltd. | $2.3B | $53.16 | $55.00 | +3.5% | Hold | 12.4x | 9 |
Quick answers to the most common questions about buying AIRS stock.
The consensus Wall Street price target for AIRS is $4.5, representing 108.3% upside from the current price of $2.16. With 5 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
AIRS has a consensus rating of "Hold" based on 5 Wall Street analysts. The rating breakdown is mixed, with 3 Hold ratings making up the largest segment. The consensus 12-month price target of $4.5 implies 108.3% upside from current levels.
AIRS's current price is $2.16 with a consensus target of $4.5 (108.3% implied move). Analyst estimates suggest the stock is undervalued at current levels.
The most bullish Wall Street analyst has a price target of $4.5 for AIRS, while the most conservative target is $4.5. The consensus of $4.5 represents the median expectation. These targets typically reflect 12-month expectations.
AIRS is moderately covered, with 5 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 3 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month AIRS stock forecast based on 5 Wall Street analysts shows a consensus price target of $4.5, with estimates ranging from $4.5 (bear case) to $4.5 (bull case). The median consensus rating is "Hold".
Wall Street analysts are very optimistic on AIRS, with a "Hold" consensus rating and $4.5 price target (108.3% upside). 2 of 5 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
AIRS analyst price targets range from $4.5 to $4.5, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $4.5 consensus represents the middle ground.
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.